Top Markets
Coin of the day
IRRAS AB (publ) IRRAS AB (publ)

IRRAS AB (publ)

IRRAS
Kedudukan dalam Saham #29630
IRRAS AB (publ), a medical technology company established in 2011 and... IRRAS AB (publ), a medical technology company established in 2011 and headquartered in Stockholm, Sweden, is dedicated to developing medical solutions that enhance the lives of critically ill patients globally. The firm specializes in neurocritical care products, aiming to transform patient outcomes and address complexities inherent in current treatment methods. Among its offerings is IRRAflow, an advanced irrigating intracranial drainage system that integrates controlled drainage, automated irrigation, and continuous intracranial pressure (ICP) monitoring, used effectively for treating hemorrhagic strokes and chronic subdural hematoma. Additionally, IRRAS provides the Hummingbird ICP monitoring system, comprising the HICP200 Control Module and various catheters like the H610 for quad ICP monitoring with drainage and the H110 for solo ICP monitoring. These Hummingbird neuromonitoring tools are vital for managing patients with elevated ICP caused by conditions such as traumatic brain injury, subarachnoid hemorrhage, and strokes. The company distributes its products to hospitals through both its direct sales force and a network of strategic distribution partners.
Harga Saham
$0.01791564
Disegerakkan terakhir: 2023-11-03
Modal Pasaran
$20.30M
Perubahan (1 hari)
22.81%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan IRRAS AB (publ) (IRRAS)

Kategori

EPS untuk IRRAS AB (publ) (IRRAS)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham IRRAS AB (publ), EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk IRRAS AB (publ) dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa